KYNTRA BIO, INC. (KYNB) Return on equity 2016–2021
KYNTRA BIO, INC. (KYNB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-138.7%FY2021 · since FY2016: -37.3% → -138.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -138.7% | -93.8 pp |
| FY2020 | -44.8% | -29.9 pp |
| FY2019 | -14.9% | +2.1 pp |
| FY2018 | -17.0% | +5.9 pp |
| FY2017 | -22.9% | +14.4 pp |
| FY2016 | -37.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross profitKYNB Gross marginKYNB Operating incomeKYNB Operating marginKYNB Operating cash flowKYNB Free cash flowKYNB Capital expendituresKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →